`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`GOOGLE LLC,
`
`Petitioner,
`
`v.
`
`JAWBONE INNOVATIONS, LLC,
`
`Patent Owner.
`
`
`
`
`
`
`
`
`Case IPR2022-00649
`
`Patent No. 8,019,091
`
`
`
`
`
`
`
`
`PETITIONER’S PRE-INSTITUTION REPLY
`
`
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`
`I.
`II.
`
`Table of Contents
`
`The Petition Presents Compelling Evidence of Unpatentability ..................... 1
`The Fintiv Factors Favor Institution ................................................................ 2
`A.
`Fintiv Factors 2, 3, 4, and 6 Favor Institution ....................................... 2
`B.
`Factors 1 and 5 Are Neutral .................................................................. 5
`III. Conclusion ....................................................................................................... 5
`
`
`i
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`Because the Petition presents compelling evidence of unpatentability, the
`
`Board should institute review and not apply the Fintiv factors. But even if the factors
`
`are applied, the most relevant Fintiv factors (2, 3, and 4) favor institution.
`
`I.
`
`The Petition Presents Compelling Evidence of Unpatentability
`The Board will not deny institution based on the Fintiv factors “where a
`
`petition presents compelling evidence of unpatentability.” Memorandum from
`
`Director Vidal, Interim Procedure for Discretionary Denials in AIA Post-Grant
`
`Proceedings with Parallel District Court Litigation at 2 (USPTO June 21, 2022)
`
`(“Interim Procedure”). Here, Petitioner has shown that the claims are unpatentable
`
`by a preponderance of the evidence. Most challenged claims are rendered obvious
`
`by the combination of Al-Kindi (Ex. 1005), Bartlett (Ex. 1006), and Alcivar
`
`(Ex. 1007). Paper 1 (“Pet.”) 8-58. The rest are rendered obvious by the addition of
`
`Hussain (Ex. 1008) or Romesburg (Ex. 1009). Pet. 58-75. Patent Owner’s contrary
`
`arguments lack merit. Paper 6 at 3-12 (“Prelim. Resp.”). As the Petition explains,
`
`supported by Petitioner’s expert Dr. Anderson, it would have been obvious to use
`
`Alcivar’s tissue-conduction microphone as Al-Kindi’s speech detector, Pet. 19-22,
`
`and Al-Kindi discloses the claimed first and second transfer functions, W1(z) and
`
`W2(z), being generated in response to the corresponding voicing activity
`
`determination from the speech detector (e.g., no speech (S(z)=0) for W1(z);
`
`speech/talkspurt for W2(z)), Pet. 29-38.
`
`1
`
`
`
`II. The Fintiv Factors Favor Institution
`In addition to the merits, the Fintiv factors either favor institution or are
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`
`neutral. The Board should institute review.
`
`A. Fintiv Factors 2, 3, 4, and 6 Favor Institution
`Factor 2 favors institution because the Board’s projected final written decision
`
`date (November 3, 2023) is several months before the expected trial date, based on
`
`the median time to trial in the Western District of Texas (January 30, 2024). Interim
`
`Procedure at 8-9. Patent Owner relies on the district court’s scheduled trial date for
`
`this factor. Prelim. Resp. 15. But a court’s scheduled trial date is often “unreliable”
`
`and “not by itself a good indicator of whether the district court trial will occur before
`
`the statutory deadline for a final written decision.”1 Interim Procedure at 8. To assess
`
`time to trial more reliably, the Board should consider the “median time-to-trial for
`
`civil actions in the district court in which the parallel litigation resides,” along with
`
`“the number of cases before the judge in the parallel litigation and the speed and
`
`availability of other case dispositions.” Id. at 8-9.
`
`The most recent Federal Court Management Statistics show that the median
`
`
`1 Indeed, the parallel litigation in Fintiv—in the same venue as the co-pending
`
`litigation here—still has not gone to trial more than a year after the final written
`
`decision would have been due. Ex. 1030 at 21, 32-33, 50, 51-53.
`
`2
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`time from the filing of a civil case to trial in the Western District of Texas is 28.3
`
`months, placing the expected trial date in the parallel litigation around January 30,
`
`2024. Ex. 1029 at 5. This is later than the November 3, 2023 statutory deadline for
`
`a final written decision in this proceeding. This favors institution. Hanwha Sols.
`
`Corp. v. Rec Solar Pte. Ltd., IPR2021-00989, Paper 12 at 14 (Dec. 13, 2021). Judge
`
`Albright’s high volume of patent cases—848 open cases as of August 2022—also
`
`makes it less likely that trial will proceed on schedule. Ex. 1031 at 68. Petitioner has
`
`also moved to transfer the litigation to the Northern District of California, another
`
`reason to doubt the scheduled trial date. Ex. 1032. Judge Albright has already
`
`delayed the Markman hearing by almost two months, demonstrating that scheduled
`
`dates are not reliable. Compare Ex. 1023 at 2, with Ex. 1036.
`
`Even relying on the court’s current trial date of July 26, 2023, this factor is at
`
`worst neutral. See DJI Europe B.V. v. Textron Innovations Inc., IPR2022-00162,
`
`Paper 11 at 10-11 (June 7, 2022) (weighing this factor neutral when the scheduled
`
`trial was two months before the projected FWD). Patent Owner’s cited cases do not
`
`dictate otherwise, see Prelim. Resp. 15-16, as they involved larger gaps between the
`
`two dates, and all but one predate Fintiv and apply a different analysis. Patent Owner
`
`also exaggerates the gap between the scheduled trial date and the projected final
`
`written decision, stating that a decision would issue “more than four months later,”
`
`when the gap is barely more than three months—assuming the decision issues on the
`
`3
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`
`last possible day, which is unlikely. Id. at 15.
`
`Factor 3 favors institution because the litigation is still in its early stages and
`
`Petitioner diligently filed its Petition. The district court has not issued any
`
`substantive orders related to the ’091 patent in the litigation. Indeed, the proper
`
`venue has not even been resolved. Ex. 1032; Ex. 1033; Ex. 1035. Judge Albright
`
`delayed the Markman hearing nearly two months until September 22, 2022.
`
`Ex. 1036. When the Board issues its institution decision, the parties will have
`
`expended few resources in the case. Based on the original Markman date, discovery
`
`just opened on July 28, 2022 (Ex. 1023 at 2) and, based on the current schedule, does
`
`not close until nearly four months after the Board’s projected institution decision (id.
`
`at 3). The deadline to serve opening expert reports is not until March 1, 2023. Id. at
`
`3. The Markman rescheduling, however, is likely to delay the schedule and change
`
`these dates. Ex. 1034 at 13-15. The case is therefore still in its early stages, and
`
`Petitioner has acted diligently in filing the Petition. This favors institution.
`
`Progenity, Inc. v. Natera, Inc., IPR2021-00267, Paper 11 at 62-63 (June 7, 2021).
`
`Patent Owner’s lone cited case is inapposite because, there, the institution decision
`
`issued after the completion of fact and expert discovery, dispositive motions, and
`
`motions in limine. See Prelim. Resp. 21 (citing Supercell Oy v. Gree, Inc., IPR2020-
`
`00513, Paper 11 at 11-12 (June 24, 2020)). None of those aspects are present here.
`
`Factor 4 favors institution. If the Board institutes review, Petitioner stipulates
`
`4
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`that it will not challenge the validity of the ’091 patent in the parallel litigation based
`
`on the grounds advanced in the Petition or on any ground that utilizes Al-Kindi
`
`(Ex. 1005). This “sufficiently mitigates concerns about duplicative efforts and
`
`potentially conflicting decisions.” Microsoft Corp. v. WSOU Invs., LLC, IPR2021-
`
`00930, Paper 8 at 11 (Dec. 2, 2021).
`
`Factor 6 favors institution for the reasons stated in the Petition. Pet. 78-79.
`
`Patent Owner has not identified any reference that is allegedly cumulative to the
`
`Petition references.
`
`Factors 1 and 5 Are Neutral
`B.
`Factor 1 is neutral where neither party has requested a stay of the parallel
`
`litigation at the time of institution. Pet. 76; see, e.g., Sand Revolution II, LLC v.
`
`Continental Intermodal Grp.–Trucking LLC, IPR2019-01393, Paper 24 at 7 (June
`
`16, 2020) (informative). Factor 5 is also neutral, despite Petitioner and Patent Owner
`
`being the same parties in the district court case. See Protect Animals With Satellites
`
`v. OnPoint Sys., LLC, IPR2021-01483, Paper 11 at 17 (Mar. 4, 2022).
`
`III. Conclusion
`For these reasons and those in the petition, the Board should decline to
`
`exercise its discretion under 35 U.S.C. § 314(a) and should institute review.
`
`
`
`5
`
`
`
`Dated: August 22, 2022
`
`
`
`
`
`
`Petitioner’s Pre-Institution Reply
`U.S. Patent No. 8,019,091
`By: /Daniel C. Cooley/
`
`
`
`
` Daniel C. Cooley
` Backup Counsel for Petitioner
` Reg. No. 59,639
`
`6
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PETITIONER’S
`
`PRE-INSTITUTION REPLY was served on August 22, 2022, via email directed
`
`to counsel of record for the Patent Owner at the following:
`
`
`Peter Lambrianakos
`plambrianakos@fabricantllp.com
`
`Vincent J. Rubino, III
`vrubino@fabricantllp.com
`
`Alfred R. Fabricant
`ffabricant@fabricantllp.com
`
`Enrique W. Iturralde
`eiturralde@fabricantllp.com
`
`Richard Cowell
`rcowell@fabricantllp.com
`
`PTAB@fabricantllp.com
`
`
`
`
`
`By: /Daniel E. Doku/
` Daniel E. Doku
` Litigation Legal Assistant
` Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`
`
`
`
`
`
`
`Dated: August 22, 2022
`
`
`
`
`
`
`